Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats

Translational Research

Volumn 155, Issue 3, 2010, Pages 131-141

  Kono, Hiroshi ^a   Fujii, Hideki ^a   Ishii, Kenichi ^a   Hosomura, Naohiro ^a   Ogiku, Masahito ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRINITROBENZENE SULPHONIC ACID; LINOLEIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 2; MEDIUM CHAIN TRIGLYCERIDE DERIVATIVE; MESSENGER RNA; MYELOPEROXIDASE; SULFONIC ACID DERIVATIVE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HISTOPATHOLOGY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 76549113378     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.08.011     Document Type: Article

References (36)

1. Podolsky D.K. Inflammatory bowel disease (1). N Engl J Med 325 (1991) 928-937
2. Sartor R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92 (1997) 5S-11S
3. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120 (2001) 622-635
4. Sands B.E. Therapy of inflammatory bowel disease. Gastroenterology 118 (2000) S68-S82
5. Kono H., Fujii H., Asakawa M., et al. Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin. Am J Physiol Gastrointest Liver Physiol 286 (2004) G1081-G1089
6. Levi A.J. Diet in the management of Crohn's disease. Gut 26 (1985) 985-988
7. Dieleman L.A., and Heizer W.D. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin North Am 27 (1998) 435-451
8. Kono H., Fujii H., Asakawa M., et al. Protective effects of medium-chain triglycerides on the liver and the gut in rats administered endotoxin. Ann Surg 237 (2003) 246-255
9. Caradonna L., Amati L., Magrone T., Pellegrino N.M., Jirillo E., and Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6 (2000) 205-214
10. Abad C., Martinez C., Juarranz M.G., et al. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 124 (2003) 961-971
11. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., and Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989) 795-803
12. Glocker T.M. [Pathology of placenta of rats induced by fatty acid deficiency]. Rev Fac Cien Med Univ Nac Cordoba 57 (2000) 187-197
13. MacPherson B.R., and Pfeiffer C.J. Experimental production of diffuse colitis in rats. Digestion 17 (1978) 135-150
14. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
15. Kono H., Wheeler M.D., Rusyn I., et al. Gender differences in early alcohol-induced liver injury: role of CD14, NF-kB and TNF-a. Am J Physiol 278 (2000) G652-G661
16. Rivera C.A., and Thurman R.G. Tips for measuring endotoxin in plasma. Alcohol Clin Exp Res 22 (1998) 2192-2194
17. Jones P.M., Butt Y.M., and Bennett M.J. Effects of odd-numbered medium-chain fatty acids on the accumulation of long-chain 3-hydroxy-fatty acids in long-chain L-3-hydroxyacyl CoA dehydrogenase and mitochondrial trifunctional protein deficient skin fibroblasts. Mol Genet Metab 81 (2004) 96-99
18. Tliba O., Sibille P., Boulard C., and Chauvin A. Early hepatic cytokine mRNA expression in experimental rat fasciolosis. Vet Parasitol 103 (2002) 237-249
19. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., and Thurman R.G. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
20. Silva M.A., Quera R., Valenzuela J., Salim S.Y., Soderholm J.D., and Perdue M.H. Dendritic cells and toll-like receptors 2 and 4 in the ileum of Crohn's disease patients. Dig Dis Sci 53 (2008) 1917-1928
21. Radema S.A., van Deventer S.J., and Cerami A. Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100 (1991) 1180-1186
22. Kono H., Enomoto N., Connor H.D., et al. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol 278 (2000) G467-G476
23. Tsujikawa T., Ohta N., Nakamura T., et al. Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis. J Gastroenterol 36 (2001) 673-680
24. Mane J., Pedrosa E., Loren V., et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr 139 (2009) 603-610
25. Middleton S.J., Rucker J.T., Kirby G.A., Riordan A.M., and Hunter J.O. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 14 (1995) 229-236
26. Sakurai T., Matsui T., Yao T., et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN 26 (2002) 98-103
27. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
28. Ogata H., and Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm 9 (2003) 1107-1113
29. Hibi T., Inoue N., Ogata H., and Naganuma M. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 38 (2003) 36-42
30. Abreu M.T., Fukata M., and Arditi M. TLR signaling in the gut in health and disease. J Immunol 174 (2005) 4453-4460
31. Fukunaga T., Tsujikawa T., Sasaki M., Fujiyama Y., Bamba T., and Fujimiya M. A novel diamino-pyridine derivative (IS-741) attenuates rat ileitis induced by trinitrobenzene sulfonic acid. J Gastroenterol 38 (2003) 451-459
32. Caprilli R., Angelucci E., and Clemente V. Recent advances in the management of Crohn's disease. Dig Liver Dis 40 (2008) 709-716
33. Von Roon A.C., Reese G.E., Orchard T.R., and Tekkis P.P. Crohn's disease. Clin Evid (2007) 2007
34. Sandborn W.J., Hanauer S.B., Katz S., et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121 (2001) 1088-1094
35. Papadakis K.A., and Targan S.R. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119 (2000) 1148-1157
36. Grimble R.F. Immunonutrition. Curr Opin Gastroenterol 21 (2005) 216-222